Wells Fargo & Company »

Eterna Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Eterna Therapeutics (ERNA) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Eterna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eterna Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eterna Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $49 28 1.79
2023-09-30 $56 26 2.19
2023-06-30 $74 33 2.27
2022-12-31 $84 26 3.25

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Eterna Therapeutics

Cypress Point Wealth Management
Naviter Wealth
Sippican Capital Adivsors
CI Private Wealth
Vanguard Group
Baldwin Brothers
A. Montag and Associates
Royal Bank of Canada
Wells Fargo & Company
Citigroup
Jpmorgan Chase & Co
Nbc Securities
Aspire Private Capital

View all funds holding Eterna Therapeutics